LON:AZN - AstraZeneca Stock Price, News, & Analysis

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca declared a dividend on Thursday, July 26th. Investors of record on Thursday, August 9th will be given a dividend of GBX 68.40 per share on Monday, September 10th. This represents a yield of 1.19%. The ex-dividend date is Thursday, August 9th. The official announcement can be seen at this link. View AstraZeneca's Dividend History.

22 brokerages have issued 1-year price objectives for AstraZeneca's shares. Their forecasts range from GBX 4,080 to GBX 6,600. On average, they expect AstraZeneca's share price to reach GBX 5,760.47 in the next year. This suggests a possible upside of 3.2% from the stock's current price. View Analyst Price Targets for AstraZeneca.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 7 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Some companies that are related to AstraZeneca include Sanofi (SAN), Bayer (BAYN), GlaxoSmithKline (GSK), BEXIMCO PHARMAC/S GDR REGS (BXP), OTSUKA HOLDINGS/ADR (OTSKY), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Sinclair Pharma (SPH), Pharmaxis (PXS) and NanoViricides (NNVC).

Media headlines about AZN stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. AstraZeneca earned a media and rumor sentiment score of 0.18 on Accern's scale. They also assigned news articles about the biopharmaceutical company an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for AstraZeneca.

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 5,581.

AstraZeneca has a market capitalization of £61.66 billion.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.